Arabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli
Editor
ElsevierFecha de edición
2022-12-11Cita
10.1016/j.actbio.2021.10.014
Acta Biomaterialia 137 (2022): 218–237
ISSN
1742-7061 (print); 1878-7568 (online)DOI
10.1016/j.actbio.2021.10.014Financiado por
Financial support from the Eu-ropean Research Council through ERC-2015-AdG-694160 (VERDI) grant. AM is funded by grants from Instituto de Salud Carlos III through the “Miguel Servet” program (CP15/00053)Proyecto
info:eu-repo/grantAgreement/EC/H2020/694160/EU//VERDI; Gobierno de España. CP15/00053Versión del editor
https://doi.org/10.1016/j.actbio.2021.10.014Materias
Arabic gum; Biofilm; Colistin; Escherichia coli; Moxifloxacin; Nanoparticles; Osteomyelitis; MedicinaDerechos
© 2021 The Author(s)Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
Resumen
Osteomyelitis is an inflammatory process of bone and bone marrow that may even lead to patient death. Even though this disease is mainly caused by Gram-positive organisms, the proportion of bone infections caused by Gram-negative bacteria, such as Escherichia coli, has significantly increased in recent years. In this work, mesoporous silica nanoparticles have been employed as platform to engineer a nanomedicine able to eradicate E. coli- related bone infections. For that purpose, the nanoparticles have been loaded with moxifloxacin and further functionalized with Arabic gum and colistin (AG+CO-coated MX-loaded MSNs). The nanosystem demonstrated high affinity toward E. coli biofilm matrix, thanks to AG coating, and marked antibacterial effect because of the bactericidal effect of moxifloxacin and the disaggregating effect of colistin. AG+CO-coated MX-loaded MSNs were able to eradicate the infection developed on a trabecular bone in vitro and showed pronounced antibacterial efficacy in vivo against an osteomyelitis provoked by E. coli. Furthermore, AG+CO-coated MX-loaded MSNs were shown to be essentially non-cytotoxic with only slight effect on cell proliferation and mild hepatotoxicity, which might be attributed to the nature of both antibiotics. In view of these results, these nanoparticles may be considered as a promising treatment for bone infections caused by enterobacteria, such as E. coli, and introduce a general strategy against bone infections based on the implementation of antibiotics with different but complementary activity into a single nanocarrier. Statement of significance: In this work, we propose a methodology to address E.coli bone infections by using moxifloxacin-loaded mesoporous silica nanoparticles coated with Arabic gum containing colistin (AG+CO-coated MX-loaded MSNs). The in vitro evaluation of this nanosystem demonstrated high affinity toward E. coli biofilm matrix thanks to the Arabic gum coating, a disaggregating and antibacterial effect of colistin, and a remarkable antibiofilm action because of the bactericidal ability of moxifloxacin and colistin. This anti-E. coli capacity of AG+CO-coated MX-loaded MSNs was brought out in an in vivo rabbit model of osteomyelitis where the nanosystem was able to eradicate more than 90% of the bacterial load within the infected bone
Lista de ficheros
Tamaño
8.847Mb
Formato
PDF
Descripción
Artículo principal
Tamaño
12.97Kb
Formato
Microsoft Word 2007
Descripción
Suplemento1
Tamaño
929.1Kb
Formato
imagen PNG
Descripción
Suplemento2
Google Scholar:Aguilera-Correa, John Jairo
-
Gisbert-Garzarán, M.
-
Mediero, Aránzazu
-
Carias-Cálix, Rafael Alfredo
-
Jiménez-Jiménez, C.
-
Esteban Moreno, Jaime
-
Vallet-Regí, María
Lista de colecciones del ítem
Registros relacionados
Mostrando ítems relacionados por título, autor, creador y materia.